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The differences between intrinsic aging and photoaging 
are reviewed. The various model systems currently 
employed for the studies of aging and photoaging are 
discussed. Findings on age associated decrements in 
receptor/ligand mediated signaling as well as changes 
during cellular senescence in the expression of nuclear 
transcription factors are described. The role of telomere 
shortening and oxidative damage in the aging process is 
DEFINITION 
Intrinsic aging defmes those changes observed throughout all individuals 
with the passage of time; whereas photoaging consists of those changes 
attributable to habitual sun exposure superimposed on intrinsic aging, 
with resulring marked variability among body sites and among indi­
viduals. Photoaging is a prototypic interaction of innate biologic 
processes with environmental influences. 
EXPERIMENTAL SYSTEMS 
Currently, four model systems are used to investigate the aging process 
at the cellular and molecular levels (Table I), these are described below. 
Lower organisms are used to identify genes associated with 
aging and/ or longevity, and their homologs in higher organisms 
are then sought Genetic analysis of the yeast Saccharomyces cerevisiae 
has led to cloning of genes whose expression is associated with increased 
number of progeny of an individual cell, interpreted as an extended life­
span. These genes include LA Gland LA Cl that encode transmembrane 
proteins of as yet undetermined function (D'mello et ai, 1994), and 
RAS2 that encodes a protein involved in the activation of adenylate 
cyclase. RAS2 is reported to participate in sensing the nutritional status 
of the organism and in responding to environmental stresses, including 
ultraviolet (UV) irradiation (Broach and Deschenes, 1990 ; Sun et ai, 
1994). In addition, a specific locus in the yeast genome has been 
hypothesized to actively promote transcriptional arrest with aging. 
Indeed, a yeast mutant with increased longevity expresses an anti-aging 
protein encoded by the SIR 4 gene that appears to silence the aging 
locus and maintain gene transcription (Kennedy et ai, 1995). 
In the nematode Caenorhabditis elegans at least five genomic regions 
have been associated with longevity (Ebert et ai, 1993; Shook et ai, 
1996). The family of dqf genes controls the nematode maturation and 
directs metabolic adjustments to environmental stress . Upon activation, 
they block the maturation process and lock the organism in a larval 
form. One of the proteins encoded by a dq[ gene is a zinc finger 
protein with homology to the thyroid and steroid receptors. 
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explained. At the cellular level, genetic and behavioral 
differences between aging and photo aging are illustrated 
with particular emphasis on changes in the structure and 
function of the tumor suppressor gene p53. Key words: 
oxidative damage/p53 / senescence/telomeres/UV irradiation. 
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The age-l gene , homologous to the mammalian catalytic subunit of 
the phosphatidylinositol 3-0H kinase, is also associated with longevity, 
although it does not alter the growth rate or the maturation process 
(Dorman et ai, 1995; Larsen et ai, 1995). Interesringly, age-l confers 
increased thermal tolerance (Lithgow et ai, 1994 , 1995), and other 
longevity genes including clk-l and spe-16 confer increased tolerance 
to environmental stresses like sublethal temperature and UV irradiation 
(Murakami and Johnson, 1996), suggesting that environmental insults 
play a major role in the aging process. All longevity genes of C. elegans 
appear to affect a single downstream gene daf16 that encodes members 
of the "fork head" family of transcription factors (Ogg et ai, 1997) . 
In Drosophila, expression of genes encoding antioxidative enzymes, 
or proteins associated with resistance to starvation, desiccation, or heat 
(Rose et aI, 1992; Dudas and Arking, 1995), lead to an extended life­
span of the organism. Interesringly, th ose organisms that express higher 
resisrance to oxidative stress do not show enhanced resistance to 
starvation or heat, and vice versa, but both groups have increased life­
span, suggesting that there are multiple pathways that control longevity 
and that there is more than one route to extended life-span. 
In vitro aging (senescence) of mammalian cells This model 
developed by Hayfiick (1965) assumes that cells in vitro age similarly 
to cells in vivo. Differences in cells at early versus late passage are 
therefore considered to mimic those in young versus old donor cells 
in vivo. Studies in which young cells are fused with senescent cells 
indicate that senescence is dominant (Smith and Pereira-Smith, 1989; 
Wadhwa et ai, 1991). Chromosome transfer experiments, where a 
single normal human chromosome is introduced into immortal human 
cell lines, suggest that senescent genes reside on chromosomes 1, 4, 
and 7 (Goletz et ai, 1994). Recently, the first of these genes, MORF4, 
has been identified. It is a transcription factor containing helix-loop­
helix and leucin zipper domains (Ehrenstein, 1998). 
Several genes are overexpressed during ill vitro cellular senescence; 
however, whether these genes control senescence directly, or whether 
the changes in the expression of these genes are under the control of 
a "master switch" remains to be detertnined. The majority of genes 
overexpressed during in vitro cellular senescence contribute to blocking 
the cells in the G1 phase of the cell cycle. Some encode DNA binding 
proteins that act as regulators of gene transcription (Wistrom and 
VtIleponteau, 1992). Others, including statin (Wang and Lin, 1986) 
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Table I. Model systems for aging studies 
System 
Lower organisms 
In vi lro senescence 
(Hayflick model) 
II! vivo aging of mammalian cells 
Strengths and advantages 
Simple genetics 
Short life-span enabling longitudinal studies 
Inexpensive 
Non-invasive (abortuses) 
Longitudinal study design possible 
Minimal variability (very few cell donors) 
Cells age in vivo 
Many cell types available for studies 
Recognized environmental influences may 
be studied 
Weaknesses and disadvantages 
Indirect applicability to human aging 
Limited applicability to il! vivo aging 
Limited to few cell types 
Large interdonor variability 
Longitudinal studies very difficult 
Invasive 
Unrecognized environmental influences on cells in vivo may affect results 
Site variation 
Difficulty in achieving sufficient cell numbers 
In vivo tissue aging Inexpensive Invasive 
Large cohort possible Longitudinal studies very difficult 
Recognized environmental influences may be studied Unrecognized environmental influences on cells in vivo may affect results 
Limited to few accessible tissues 
and cyclin-dependent kinase inhibitors (see below), encode inhibitors 
of nuclear proteins. 
Other overexpressed senescence genes encode epitopes of extra­
cellular matrix proteins like fibronectin (Porter et aI, 1992), proteases 
involved in modulation of extracellular proteins like collagenase and 
stromelysin (Zeng and Millis, 1996), or protease inhibitors like 
plasminogen activator inhibitor 1 and 2 (Mu and Higgins, 1995; West 
et aI, 1996). Thus, it seems that signals from extracellular matrix 
proteins participate in the regulation of cellular proliferation. Because 
the relevance of in vitro senescence to in vivo aging remains unclear, 
however, these findings should be interpreted with caution. The 
validity of the senescence model is further discussed below. 
In vivo aging of mammalian cells In this system, the behavior of 
early passage cells obtained from young versus old donors is compared 
and is assumed to reflect the behavior of cells in intact tissues of 
young versus old individuals. When using skin-derived fibroblasts, 
keratinocytes, or melanocytes, biopsies are ideally obtained from the 
same body site and the cells are maintained in the same culture 
conditions in order to exclude outside influences. Furthermore, the 
recent development of defmed serum-free culture systems that support 
cutaneous cell growth enhance the relevance of this in vitro model for 
gerontologic studies (Gilchrest, 1983; Gilchrest et aI, 1984; Gordon 
et ai, 1988). One disadvantage of the model is that newborn cells are 
almost invariably of foreskin origin and hence usually from a different 
site or gender than cells derived from adult donors. Also, comparing 
newborn cells to adult cells may be informative regarding development 
rather than true aging. Nevertheless, this model has proved to have a 
great potential to understand aging processes. 
In situ observations investigating gene and protein expres­
sion in tissue specimens obtained from donors of different 
ages Although iii lIillo results are perhaps the most relevant findings, 
the nature of ill sit�1 observations limit their use, at least in humans, to 
a few accessible tissues. As well, ill situ studies are generally associated 
with notable donor variability and hence require a large cohort. 
Also, exclusion of environmental influences is sometimes impossible; 
however, because the target of all aging studies is the organism. ill situ 
observations have the potential to complement other experimental 
models and to enhance our understanding of the aging process. 
Perhaps the best controlled model system to investigate photo aging 
utilizes photodarnaged cells and sun-protected cells from the same 
donor. Comparisons of cellular behavior and gene or protein expression 
are perfornled in lIitro or ill situ. 
INTRINSIC AGING 
Aging is associated with a loss of maximal function and reserve capacity 
in human tissues that results from changes at the cellular level. These 
changes impair baseline function and response to environmental 
challenges. The impaired response results in decreased capacity to 
Large interdonor variability 
repair injury, predisposing the organism to disease and permanent 
dysfunction. 
Many studies have demonstrated that age-associated decrements in 
tissue function are reflected in the individual behavior of cultured cells. 
Hayfiick (1965) first demonstrated that the life-span of cells in vitro is 
inversely related to the chronologie age of the organism. He showed 
that normal human diploid cells have a fmite life-span or population 
doublings in vitro, after which they lose the capacity to divide and 
senesce. Excluding germline cells and perhaps certain stem cells. 
replicative senescence, an irreversible arrest of cellular proliferation, 
occurs in all nontransformed human cells (McCormick and Maher, 
1988). Senescence is thought to be an important protective mechanism 
against cancer development, although its relationship to aging is still 
controversial (Campisi, 1996). Nevertheless, cultured old-donor cells 
senesce after fewer population doublings than cultured young donor 
cells (Stanulis-Praeger, 1987; Cristofalo and Pignolo, 1993), and cells 
derived from organisms with shorter life-spans senesce after fewer 
population doublings than cells derived from organisms with longer 
life-spans (Stanulis-Praeger, 1987). Thus it appears plausible that the 
life-span of the organism and senescence of its individual cultured cells 
are under the same genetic control. 
Skin derived cells, including keratinocytes (Rheinwald and Green, 
1975; Gilchrest, 1983), fibroblasts (Schneider and Mitsui, 1976; 
Mets et aI, 1983), and melanocytes (Gilchrest et ai, 1984; Medrano 
et ai, 1994), also show an age-associated decrease in cumulative 
population doublings. Also, their in vitro response to mitogenic stimuli 
is decreased as a function of donor age (Stanulis-Praeger and Gilchrest, 
1986; Barrandon and Green, 1987; Stanulis-Praeger et ai, 1988; 
Reenstra et ai, 1993). 
The age-associated decreased response to mitogenic stimuli may be 
in part the result of impaired signal transduction. Recent work in 
normal human fibroblasts has demonstrated a decrease in the number 
and density of epidermal growth factor receptors (EGFR). accompanied 
by decreased ligand binding, in cells derived from old adult donors as 
compared with cells derived from young adult donors (Reenstra et ai, 
1993). Of note, these age-associated changes could be reliably detected 
only with early passage cells (Reenstra et al. 1993) and had not 
previously been observed in the Hayflick model of fibroblast aging 
when mid-passage rather than early passage cells were compared with 
late passage cells (Phillips et ai, 1983). Also, the rates of EGFR 
autophosphorylation and internalization decrease with aging (Reenstra 
et ai, 1996). Such decrements in the initial transduction of the mitogenic 
signal may adversely affect tissue function. in particular wound healing 
capacity. Indeed, several reports have established that tissue repair is 
decreased with aging (Gerstein et ai, 1993). 
Interestingly, introducing the EGFR gene into old adult fibroblasts 
restores the receptor level on the cell surface and elevates EGFR 
autophosphorylation levels to those of newborn cells, but only 
minimally increases thymidine incorporation in old adult cells after 
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mitogen stimulation (Wang B, Yaar M, and Gilchrest BA, unpublished 
data). This result indicates that other signaling pathways, downstream of 
EGFR, may be independently affected by aging, and/or that the level 
and function of other growth factor receptors, required for the full 
mitogenic response, may also be decreased in aged fibroblasts . 
Indeed, studies of the immune system using T lymphocytes derived 
from young and old mice have shown that even after bypassing the 
initial signal generated by receptor/ligand interaction and directly 
activating the intracellular enzyme protein kinase C with phorbol 12-
myristate 13-acetate (PMA) , the phosphorylation of most proteins is 
significantly reduced in old adult T lymphocytes as compared with 
young adult T lymphocytes (patel and Miller, 1992). Furthermore, the 
pattern of kinase/substrate interaction and protein phosphorylation in 
both activated and resting murine T cells varies between old and young 
cells (Ghosh and Miller, 1995; Garcia and Miller, 1997). These studies 
establish that the activity of intracellular kinases is altered with aging 
and suggest that components of the signal transduction pathway other 
than receptor/ligand interaction are also altered with aging. 
Studies using the in vitro senescence model suggest that the tumor 
supressor proteins p53 and retinoblastoma play a major role in cellular 
senescence (Hara et ai, 1996; Bond et ai, 1996). During senescence, 
profound changes are found in the expression of several nuclear 
transcription factors, including statin, which is thought to inhibit the 
early stages of retinoblastoma protein phosphorylation (Wang et ai, 
1994); p16, whose function is to inhibit activity of cyclin-dependent 
kinases (Lukas et ai, 1995); c-fos, the "master switch" activated by 
many cell signals; E2F, a family of transcription factors that induce 
expression of genes important for cell proliferation; and the dominant 
negative helix-loop-helix proteins (Id1 and Id2) that inhibit the 
activity of the basic helix-loop-helix transcription factors (Gilchrest 
and Bohr, 1997). 
The E2F transcription factors are activated only when the retino­
blastoma protein is phosphorylated. For several weeks after reaching 
proliferative senescence, cells express high levels of the p21 nuclear 
protein that inhibits the activity of cyclin-dependent kinases and 
limits retinoblastoma protein phosphorylation (Dulic et ai, 1993). p21, 
however, eventually returns to the presenescent level and still the cells 
remain incapable of cell division and thus stay in the senescent state 
(Gilchrest and Bohr, 1997). Furthermore, even if the level of E2F 
factors is increased by introducing expression vectors into senescent 
cells, cellular senescence is irreversible (Dimri et aI, 1994), suggesting 
either that the repression of the E2F factors is not required for 
senescence maintenance or that the different senescent repressors of 
DNA synthesis are dominant in their action. 
Several studies suggest that shortened telomeres playa major role in 
replicative senescence and aging. Telomeres are the terminal portion 
of eukaryotic chromosomes. They consist of up to many hundreds of 
tandem short sequence repeats (TTAGGG) and their putative role is 
to protect chromosome ends from degradation (Blackburn, 1991). 
During mitosis of somatic cells, DNA polymerase cannot replicate the 
final base pairs of each chromosome, resulting in progressive shortening 
with each round of cell division. A special reverse transcriptase, 
telomerase, can replicate these chromsomal ends, but, with a few 
exceptions, the enzyme is normally expressed only in germ-line cells 
(Sharma et ai, 1995). In vitro studies using young and old adult donor 
fibroblasts established that telomeres become progressively shorter in a 
replicative-dependent manner (Harley et ai, 1990; Harley, 1991). 
Telomere shortening was also observed during in vivo aging of fibroblasts 
and peripheral blood lymphocytes (Vaziri et aI, 1993). Telomere 
length shortened more than 30% during adulthood even in relatively 
quiescent skin fibroblasts (Allsopp et ai, 1992). In contrast, telomeres 
of immortalized or cancerous cells that display telomerase activity do 
not become progressively shorter with each population doubling 
(Counter et ai, 1994; Sugihara et ai, 1996). Furthermore, introducing 
active telomerase into normal somatic skin fibroblasts results in elonga­
tion of their telomeres and leads to extension of their growth potential 
beyond their normal senescent point (Bodnar et ai, 1998). These studies 
strongly suggest that loss of telomere sequences in normal somatic cells 
signals cell cycle arrest or apoptosis and compromises DNA stability 
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Table II. Postulated mechanisms of aging versus photoaging 
Mechanism Aging Photoaging 
Cummulative population doublings ill vitro J, U 
Response to mitogenic stimuli J, U 
Growth fuctor receptor level J, unknown 
Receptor ligand interaction J, unknown 
Intracellular signal transduction pathway activation altered altered 
Telomeres J, unknown 
Telomerase activity unknown i 
Oxidative damage i ii 
Mitochrondrial DNA mutations i ii 
p53 mutations i iii 
Differentiated status i J, 
and transcnptlOn of subtelomeric genes (Sandell and Zakian, 1993; 
Vaziri and Benchimol, 1996), contributing to the aged phenotype. 
One of the mechanisms that has been implicated in aging and 
senescence is cumulative oxidative damage to cellular constituents. 
Markers for oxidative damage of DNA and proteins increase with 
aging in both lower and higher organisms (Agarwal and Sohal, 1994; 
Lopez-Torres et ai, 1994; Shigenaga et ai, 1994; Schleicher et ai, 1997), 
and in vitro treatment of human diploid fibroblasts with low doses of 
H202 cause the cells to enter a senescent-like state (Chen and Ames, 
1994). Furthermore, gene mutations that increase resistance to oxidative 
damage increase longevity of the nematode C. elegans, suggesting that 
oxidative damage is causally related to aging (Larsen, 1993). 
Oxidative damage appears to playa role in mitochondrial aging and 
ultimately in their degeneration. Mitochondria age partly as a result of 
accumulation of DNA mutations including gene rearrangements and 
deletions (Shigenaga et ai, 1994; Melov et ai, 1995a, b). It is possible 
that similar mechanisms contribute to an age-associated increase in 
nuclear DNA mutations, although it was shown that in human cells 
oxidative stress affects mitochondrial DNA more extensively, and the 
damage persists longer, than the damage to nuclear DNA (Yakes and 
Van Houten, 1997). Nevertheless, because DNA repair capacity is 
decreased with aging (Moriwaki et ai, 1996), even relatively minor 
damage to nuclear DNA may not be promptly repaired, leading with 
time to accumulation of mutations and to the deterioration in cellular 
function or even the development of cancer. 
In summary, intrinsic aging appears to affect molecules involved in 
signal transduction, transcription factors, and the genetic integrity of 
the cell. Whether these changes are causally related remains to be 
determined. 
The postulated mechanisms that are involved in the process of 
intrinsic aging are summarized in Table II. 
PHOTOAGING 
Many of the age-associated functional losses of human cells are 
accelerated in photoaged cells. Compared with cultures derived from 
sun-protected sites (upper inner arm), cultures of keratinocytes and 
fibroblasts derived from habitually sun-exposed sites (upper outer arm) 
of the same donor have shorter in vitro life-spans and this discrepancy 
increases linearly as a function of donor age and the severity of clinically 
apparent photoaging changes (Gilchrest, 1979, 1980; Gilchrest et ai, 
1983). The reason for shortened in vitro life-span of photo aged cells is 
unknown, but has been postulated to reflect increased compensatory 
population doubling in habitually UV-damaged skin, compared with 
cells in nondamaged skin. 
A growing body of evidence also suggests that reactive oxygen 
species are generated by UV irradiation, leading to enhanced oxidative 
damage in chronically sun-exposed skin (Miyachi, 1995). Increased 
oxidative stress may lead to increased mitochondrial and nuclear 
DNA damage (Gilchrest and Bohr, 1997), accelerating cellular aging 
on the one hand and contributing to the development of skin cancer 
on the other hand. 
A principal difference between intrinsically aged skin and photoaged 
skin is the propensity of the latter to develop malignancies (Gallagher 
et ai, 1990), presumably because causative mutations in oncogenes and/ 
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or tumor suppressor genes are far more prevalent in photo damaged 
skin. 111 lJitro and il1 vivo studies demonstrate that UV irradiation directly 
interacts with DNA at dipyrimidine sites to produce CC-tTT or 
C-tT "signature" mutations (Ziegler et ai, 1993). Because cancer 
initiation requires several independent mutations in a single cell (Caims, 
1975; Vogelstein and Kinzler, 1 993) , it is likely that in photodamaged 
skin there would be populations of mutated cells that are not yet 
cancerous. Indeed, in both murine and human studies, p53 mutations 
were found in otherwise normal UV-exposed skin Oonason et ai, 1996; 
Tong et ai, 1997). Interestingly, clones of p5�, mutated keratinocytes 
were found at the denno-epidermal junction in both sun-exposed and 
sun-protected human skin, but in sun-exposed skin the clones were 
larger, more frequent Oonason et ai, 1996), and the mutations were 
located at "UV hotspots" or dipyrimidine sites (Ziegler et ai, 1993, 
1994; Bito el ai, 1995; Jonason el ai, 1996). p53 mutations were also 
found in actinic keratoses and squamous cell carcinomas and in 
perilesional clinically normal skin (Ziegler et ai, 1994), suggesting that 
mutations of the p53 tumor suppressor gene are an early event in UV­
induced carcinogenesis . 
Further evidence for p53 mutations in chronically sun-exposed 
human skin comes from studies examining the level of the p53 
regulated nuclear protein, p21. Some areas of chronically sun-exposed 
skin coordinately express p53 and p21, as expected (el-Deiry et aI, 
1993). In contrast , in other regions of chronically sun-exposed skin, 
as well as in solar keratoses and squamous cell carcinomas, p53 positive 
regions do not express p21, suggesting that p53 in these regions is 
mutated (an event known to frequently slow p53 protein degradation 
and hence lead to its overexpression) and has Itherefore lost its nom1al 
transcriptional function, including the ability to induce p21 (Inohara 
et ai, 1996). Whether UV-induced mutations in p53 and other 
regulatory or structural genes contribute to the photoaging phenotype, 
as with malignancy, is unknown but seems likely, if only because of 
the very large number of cumulative mutations expected to occur in 
habitually sun-exposed skin (Brash and Bale, 1997). 
Interestingly, telomerase, a ribonucleoprotein enzyme that under 
normal conditions maintains telomere length primarily in germ line 
cells (Greider, 1994), is reactivated in human cancers (Counter et ai, 
1994; Broccoli et ai, 1995; Chadeneau et ai, 1995), including cutaneous 
basal and squamous cell carcinomas (Taylor et ai, 1996). Furthermore, 
increased telomerase activity is found in photo damaged skin (Taylor 
et ai, 1996; Ueda et ai, 1997); however, because telomerase activity 
was found in normal skin as well as in skin affected by inflammatory 
dermatoses (Taylor et ai, 1996), further studies are required to establish 
that telomerase reactivation is involved in the early stages of UV­
induced carcinogenesis. A relationship between telomere shortening 
and photoaging , if any, has not been established. 
Genetic differences between intrinsically ag .ed skin cells and photo­
damaged skin cells would predict behavioral differences for these cells 
in vitro. Indeed, studies from our laboratory using fibroblasts and 
keratinocytes derived from sun-exposed and sun-protected skin of the 
same individuals have demonstrated such differences. First, the baseline 
expression of SPR2, which encodes a differentiation-associated 
cornified envelope protein, and of the interleukin 1 receptor antagonist, 
which is increased during keratinocyte differentiation (Bigler et ai, 
1992) , is lower in keratinocytes derived from habitually sun-exposed 
skin than from sun-protected skin of the same old adult donors 
(Garmyn et ai, 1992). These data support the concept that photoaged 
keratinocytes have an altered (higher) threshold for terminal differ­
entiation. In addition, the response of chronically photoaged keratino­
cytes to acute UV irradiation also differs. In response to UV irradiation, 
the expression of the rapidly induced proto-oncogene c-fos is several­
fold higher in keratinocytes derived from photodamaged skin of old 
adults than in keratinocytes derived £i'om sun-protected skin of the 
same donors (Gam1yn et ai, 1992). It is tempting to speculate that 
increased UV inducibility of one or more key proto-oncogenes, in 
combination with a reduced state of differentiation, may predispose 
cells in photoaged skin to photocarcinogenesis. 
In conclusion, photoaged cells seem to hd.ve lost, at least in part, 
their ability to differentiate normally. This aberrant behavior appears 
JID SYMPOSIUM PROCEEDINGS 
to result at least in part from UV-induced mutations. Table II 
sul11l11arizes the postulated mechanisms that are involved in photoaging . 
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